• Home
  • Wacker Biotech GmbH

Wacker Biotech GmbH

About Wacker Biotech GmbH

WACKER is a global chemical company with annual sales of around € 6.4 billion (2023). We provide cyclodextrins and complexes, building blocks for drugs and pesticides, pharmaceutical excipients. Through its subsidiary Wacker Biotech, WACKER also provides contract process development and GMP manufacturing of nucleic acid-based therapeutics, proteins, vaccines and Live Biotherapeutic Products.

Read more Show less
Certifications
  • CE
    CE
  • FDA
    FDA
  • GMP
    GMP
  • ISO
    ISO
  • Other
More certifications Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    Germany
  • On CPHI since:
    2021
  • Certificates:
    5
  • Employees:
    5000+
Company types
Biopharmaceutical company
CMO/CDMO
Contract Service
Drug delivery device Supplier/Manufacturer
Manufacturer/Innovator
Primary activities
API Producer
Biopharmaceutical
Chemical Development
Contract Manufacturer
Excipients Manufacturer
Fine Chemicals Company
Generic APIs producer
Intermediates Manufacturer
Nutraceuticals
Contact info
Show contact info Hide contact info

Products from Wacker Biotech GmbH (1)

  • Cyclodextrin, CAVAMAX®, CAVASOL®

    Product Cyclodextrin, CAVAMAX®, CAVASOL®

    WACKER is the only company worldwide offering all three parent cyclodextrins, which are marketed under the trademark CAVAMAX®. WACKER also manufactures and offers chemically modified cyclodextrin derivatives, which are marketed under the trademark CAVASOL®. The modification of the guest with this mol...